Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vitamin D levels in Hispanics with multiple sclerosis.
Amezcua L, Chung RH, Conti DV, Langer-Gould AM. Amezcua L, et al. J Neurol. 2012 Dec;259(12):2565-70. doi: 10.1007/s00415-012-6537-z. Epub 2012 May 16. J Neurol. 2012. PMID: 22588255
Native ancestry is associated with optic neuritis and age of onset in hispanics with multiple sclerosis.
Amezcua L, Beecham AH, Delgado SR, Chinea A, Burnett M, Manrique CP, Gomez R, Comabella M, Montalban X, Ortega M, Tornes L, Lund BT, Islam T, Conti D, Oksenberg JR, McCauley JL. Amezcua L, et al. Ann Clin Transl Neurol. 2018 Sep 23;5(11):1362-1371. doi: 10.1002/acn3.646. eCollection 2018 Nov. Ann Clin Transl Neurol. 2018. PMID: 30480030 Free PMC article.
The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States.
Beecham AH, Amezcua L, Chinea A, Manrique CP, Rubi C, Isobe N, Lund BT, Santaniello A, Beecham GW, Burchard EG, Comabella M, Patsopoulos N, Fitzgerald K, Calabresi PA, De Jager P, Conti DV, Delgado SR, Oksenberg JR, McCauley JL. Beecham AH, et al. Among authors: amezcua l. Mult Scler. 2020 Oct;26(11):1329-1339. doi: 10.1177/1352458519863764. Epub 2019 Aug 1. Mult Scler. 2020. PMID: 31368393 Free PMC article.
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Cree BAC, Cutter G, Wolinsky JS, Freedman MS, Comi G, Giovannoni G, Hartung HP, Arnold D, Kuhle J, Block V, Munschauer FE, Sedel F, Lublin FD; SPI2 investigative teams. Cree BAC, et al. Lancet Neurol. 2020 Dec;19(12):988-997. doi: 10.1016/S1474-4422(20)30347-1. Epub 2020 Oct 23. Lancet Neurol. 2020. PMID: 33222767 Clinical Trial.
72 results